{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T05:32:42Z","timestamp":1740202362895,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-028"],"award-info":[{"award-number":["2022-PUMCH-C-028"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-C&T-B-002"],"award-info":[{"award-number":["2021-I2M-C&T-B-002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["no. 81770427\uff0cno. 82070822"],"award-info":[{"award-number":["no. 81770427\uff0cno. 82070822"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04094-7","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:51:24Z","timestamp":1731545484000},"page":"1267-1275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Why do patients with pheochromocytomas\/paragangliomas exhibit significantly inconsistent elevation of catecholamines and their metabolites? a large Chinese cohort study"],"prefix":"10.1007","volume":"87","author":[{"given":"Yue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TianYi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-1012","authenticated-orcid":false,"given":"Anli","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"4094_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","volume":"43","author":"S N\u00f6lting","year":"2022","unstructured":"S. N\u00f6lting, N. Bechmann, D. Taieb, F. Beuschlein, M. Fassnacht, M. Kroiss et al. Personalized management of pheochromocytoma and paraganglioma. Endocr. Rev. 43, 199\u2013239 (2022). https:\/\/doi.org\/10.1210\/endrev\/bnab019","journal-title":"Endocr. Rev."},{"key":"4094_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","volume":"100","author":"S Pillai","year":"2016","unstructured":"S. Pillai, V. Gopalan, R.A. Smith, A.K. Lam, Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit. Rev. Oncol.\/Hematol. 100, 190\u2013208 (2016). https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.022","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"4094_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","volume":"51","author":"G Eisenhofer","year":"2005","unstructured":"G. Eisenhofer, J.W. Lenders, D.S. Goldstein, M. Mannelli, G. Csako, M.M. Walther et al. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin. Chem. 51, 735\u2013744 (2005). https:\/\/doi.org\/10.1373\/clinchem.2004.045484","journal-title":"Clin. Chem."},{"key":"4094_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2125.1981.tb01210.x","volume":"12","author":"MJ Brown","year":"1981","unstructured":"M.J. Brown, D.J. Allison, Renal conversion of plasma DOPA to urine dopamine. Br. J. Clin. Pharmacol. 12, 251\u2013253 (1981). https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01210.x","journal-title":"Br. J. Clin. Pharmacol."},{"key":"4094_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/cs0920423","volume":"92","author":"E Eldrup","year":"1997","unstructured":"E. Eldrup, S.E. M\u00f8ller, J. Andreasen, N.J. Christensen, Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid. Clin. Sci. 92, 423\u2013430 (1997). https:\/\/doi.org\/10.1042\/cs0920423","journal-title":"Clin. Sci."},{"key":"4094_CR6","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jcem.82.11.4339","volume":"82","author":"G Eisenhofer","year":"1997","unstructured":"G. Eisenhofer, A. Aneman, P. Friberg, D. Hooper, L. F\u00e5ndriks, H. Lonroth et al. Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab. 82, 3864\u20133871 (1997). https:\/\/doi.org\/10.1210\/jcem.82.11.4339","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4094_CR7","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","volume":"83","author":"G Eisenhofer","year":"1998","unstructured":"G. Eisenhofer, H. Keiser, P. Friberg, E. Mezey, T.T. Huynh, B. Hiremagalur et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J. Clin. Endocrinol. Metab. 83, 2175\u20132185 (1998). https:\/\/doi.org\/10.1210\/jcem.83.6.4870","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4094_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/endrev\/bnad011","volume":"44","author":"G Eisenhofer","year":"2023","unstructured":"G. Eisenhofer, C. Pamporaki, J.W.M. Lenders, Biochemical assessment of pheochromocytoma and paraganglioma. Endocr. Rev. 44, 862\u2013909 (2023). https:\/\/doi.org\/10.1210\/endrev\/bnad011","journal-title":"Endocr. Rev."},{"key":"4094_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","volume":"64","author":"G Eisenhofer","year":"2018","unstructured":"G. Eisenhofer, A. Prejbisz, M. Peitzsch, C. Pamporaki, J. Masjkur, N. Rogowski-Lehmann et al. Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites. Clin. Chem. 64, 1646\u20131656 (2018). https:\/\/doi.org\/10.1373\/clinchem.2018.291369","journal-title":"Clin. Chem."},{"key":"4094_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"J.W. Lenders, K. Pacak, M.M. Walther, W.M. Linehan, M. Mannelli, P. Friberg et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427\u20131434 (2002). https:\/\/doi.org\/10.1001\/jama.287.11.1427","journal-title":"JAMA"},{"key":"4094_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s40618-023-02239-5","volume":"47","author":"Y Cui","year":"2024","unstructured":"Y. Cui, Y. Zhou, Y. Gao, X. Ma, Y. Wang, X. Zhang et al. Novel alternative tools for metastatic pheochromocytomas\/paragangliomas prediction. J. Endocrinol. Investig. 47, 1191\u20131203 (2024). https:\/\/doi.org\/10.1007\/s40618-023-02239-5","journal-title":"J. Endocrinol. Investig."},{"key":"4094_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"O. Mete, S.L. Asa, A.J. Gill, N. Kimura, R.R. de Krijger, A. Tischler, Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr. Pathol. 33, 90\u2013114 (2022). https:\/\/doi.org\/10.1007\/s12022-022-09704-6","journal-title":"Endocr. Pathol."},{"key":"4094_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/joim.13791","volume":"296","author":"SS Park","year":"2024","unstructured":"S.S. Park, C.H. Ahn, S. Lee, W. Lee, W.W. Kim, Y.M. Lee et al. Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: a cohort study. J. Intern. Med. 296, 68\u201379 (2024). https:\/\/doi.org\/10.1111\/joim.13791","journal-title":"J. Intern. Med."},{"key":"4094_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cen.14585","volume":"96","author":"L Liu","year":"2022","unstructured":"L. Liu, W. Xie, Z. Song, T. Wang, X. Li, Y. Gao et al. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: which is the best diagnostic strategy. Clin. Endocrinol. 96, 132\u2013138 (2022). https:\/\/doi.org\/10.1111\/cen.14585","journal-title":"Clin. Endocrinol."},{"key":"4094_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1530\/eje-13-0529","volume":"169","author":"N van Duinen","year":"2013","unstructured":"N. van Duinen, E.P. Corssmit, W.H. de Jong, D. Brookman, I.P. Kema, J.A. Romijn, Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites. Eur. J. Endocrinol. 169, 377\u2013382 (2013). https:\/\/doi.org\/10.1530\/eje-13-0529","journal-title":"Eur. J. Endocrinol."},{"key":"4094_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1530\/eje-09-0996","volume":"162","author":"E Grouzmann","year":"2010","unstructured":"E. Grouzmann, L. Drouard-Troalen, E. Baudin, P.F. Plouin, B. Muller, D. Grand et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur. J. Endocrinol. 162, 951\u2013960 (2010). https:\/\/doi.org\/10.1530\/eje-09-0996","journal-title":"Eur. J. Endocrinol."},{"key":"4094_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/00313020802579284","volume":"41","author":"PE Hickman","year":"2009","unstructured":"P.E. Hickman, M. Leong, J. Chang, S.R. Wilson, B. McWhinney, Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology 41, 173\u2013177 (2009). https:\/\/doi.org\/10.1080\/00313020802579284","journal-title":"Pathology"},{"key":"4094_CR18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/HJH.0b013e32813aeb5a","volume":"25","author":"J V\u00e1clav\u00edk","year":"2007","unstructured":"J. V\u00e1clav\u00edk, D. Stejskal, B. Lacn\u00e1k, M. Laz\u00e1rov\u00e1, L. Jedelsk\u00fd, L. Kadalov\u00e1 et al. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J. Hypertens. 25, 1427\u20131431 (2007). https:\/\/doi.org\/10.1097\/HJH.0b013e32813aeb5a","journal-title":"J. Hypertens."},{"key":"4094_CR19","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1210\/jc.2005-2668","volume":"92","author":"JG Boyle","year":"2007","unstructured":"J.G. Boyle, D.F. Davidson, C.G. Perry, J.M. Connell, Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J. Clin. Endocrinol. Metab. 92, 4602\u20134608 (2007). https:\/\/doi.org\/10.1210\/jc.2005-2668","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4094_CR20","doi-asserted-by":"publisher","unstructured":"L. Zhao, X. Zhang, X. Meng, T. Zhang, H. Fan, Q. Zhang, et al. The clinical characteristics of pheochromocytomas and paragangliomas with negative catecholamines. J. Clin. Med. 11, 5583 https:\/\/doi.org\/10.3390\/jcm11195583 (2022)","DOI":"10.3390\/jcm11195583"},{"key":"4094_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12020-021-02816-9","volume":"74","author":"A Kawashima","year":"2021","unstructured":"A. Kawashima, M. Sone, N. Inagaki, K. Okamoto, M. Tsuiki, S. Izawa et al. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases. Endocrine 74, 155\u2013162 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02816-9","journal-title":"Endocrine"},{"key":"4094_CR22","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2008-1093","volume":"93","author":"HJ Timmers","year":"2008","unstructured":"H.J. Timmers, K. Pacak, T.T. Huynh, M. Abu-Asab, M. Tsokos, M.J. Merino et al. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J. Clin. Endocrinol. Metab. 93, 4826\u20134832 (2008). https:\/\/doi.org\/10.1210\/jc.2008-1093","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4094_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/hypertensionaha.123.21902","volume":"81","author":"O Petr\u00e1k","year":"2024","unstructured":"O. Petr\u00e1k, Z. Kr\u00e1tk\u00e1, R. Holaj, M. Z\u00edtek, T. Nguyen Nikr\u00fdnov\u00e1, J. Kl\u00edmov\u00e1 et al. Cardiovascular complications in pheochromocytoma and paraganglioma: does phenotype matter? Hypertension 81, 595\u2013603 (2024). https:\/\/doi.org\/10.1161\/hypertensionaha.123.21902","journal-title":"Hypertension"},{"key":"4094_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1021420","volume":"13","author":"G Constantinescu","year":"2022","unstructured":"G. Constantinescu, C. Preda, V. Constantinescu, T. Siepmann, S.R. Bornstein, J.W.M. Lenders et al. Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology. Front Endocrinol. (Lausanne) 13, 1021420 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.1021420","journal-title":"Front Endocrinol. (Lausanne)"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04094-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:20:44Z","timestamp":1740147644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04094-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["4094"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04094-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the institutional review board of the Peking Union Medical College Hospital in Beijing, China. Written informed consent was obtained from all patients. The authors affirm that all patients provided informed consent for publication of their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}